ArticleOPEN ACCESS

Peripheral T-cell lymphoma: Novel backbone

Blood
DOI: 10.1182/blood-2017-11-817734
4Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In this issue of Blood, Amengual et al report the results of a single-institution dose-escalation phase 1 study of pralatrexate plus romidepsin for patients with relapsed/refractory non-Hodgkin lymphoma. This combination resulted in a very high response rate in patients with previously treated peripheral T-cell lymphoma (PTCL) 1 .

Cite

CITATION STYLE

APA

Vose, J. M. (2018, January 25). Peripheral T-cell lymphoma: Novel backbone. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2017-11-817734

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free